Related references
Note: Only part of the references are listed.Blockade of Cannabinoid Receptor 1 Improves Insulin Resistance, Lipid Metabolism, and Diabetic Nephropathy in db/db Mice
D. H. Nam et al.
ENDOCRINOLOGY (2012)
Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality
Mark Hamer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
Francisco Javier Bermudez-Silva et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity
E. Heyman et al.
OBESITY REVIEWS (2012)
Characterizing the profile of obese patients who are metabolically healthy
V. Primeau et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Cholecystokinin Exerts an Effect via the Endocannabinoid System to Inhibit GABAergic Transmission in Midbrain Periaqueductal Gray
Vanessa A. Mitchell et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle
K. A. Lindborg et al.
DIABETES OBESITY & METABOLISM (2010)
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients
Giovanni Annuzzi et al.
LIPIDS IN HEALTH AND DISEASE (2010)
The multiple functions of the endocannabinoid system: a focus on the regulation of food intake
Eduardo Tibirica
DIABETOLOGY & METABOLIC SYNDROME (2010)
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
V. Di Marzo et al.
DIABETOLOGIA (2009)
Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases
Sivaram Pillarisetti et al.
DRUG DISCOVERY TODAY (2009)
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects
Vincenzo Di Marzo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Resistance Training Does Not Contribute to Improving the Metabolic Profile after a 6-Month Weight Loss Program in Overweight and Obese Postmenopausal Women
Martin Brochu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Endocannabinoid System: Potential for Reducing Cardiometabolic Risk
Henry N. Ginsberg et al.
OBESITY (2009)
Identification and characterization of metabolically benign obesity in humans
Norbert Stefan et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Endocannabinoid System Overactivity and the Metabolic Syndrome: Prospects for Treatment
Jennifer M. Perkins et al.
CURRENT DIABETES REPORTS (2008)
The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids
Tara M. D'Eon et al.
DIABETES (2008)
The endocannabinoid system in obesity and type 2 diabetes
V. Di Marzo
DIABETOLOGIA (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: A monet study
Martin Brochu et al.
OBESITY (2008)
Role and regulation of acylethanolamides in energy balance:: focus on adipocytes and β-cells
I. Matias et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Endocannabinoid system and cardiometabolic risk
L. E. Saavedra
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease
James B. Meigs et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
Isabel Matias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
The metabolically healthy but obese individual presents a favorable inflammation profile
AD Karelis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The continuing epidemics of obesity and diabetes in the United States
AH Mokdad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
